U.S. Vaccines Derived From Abortion
|Disease||Vaccine Name||Manufacturer||Cell line (Fetal)|
|Measles, Mumps, Rubella
|Merck & Company||WI-38|
Merck & Company
|Hepatitis A-B Combo||Twinrix||Glaxo/SmithKline||MRC-5|
|Chickenpox||Varivax||Merck & Company||WI-38 and MRC-5|
|Ebola||Unknown||Crucell & N.I.H.||PER C6|
|HIV||Unknown||Merck & Company||PER C6|
For more information on Xigris, PER C6, 293 Cell Lines and AD5 Vectors
|Vaccine Name||Manufacturer||Cell line|
|Polio||IPOL||Aventis-Pasteur||Monkey kidney cells|
|Mumps||Mumpsvax||Merck & Company||Chick embryo|
|Rabies||RabAvert||Chiron Therapeutics||Chick embryo|
|Measles||Attenuvax||Merck & Company||Chick Embryo|
|Smallpox||Acambis 2000||Acambis-Baxter||Vero (Monkey)|
Vaccine Alternatives Available In The
NOT FDA APPROVED FOR USE IN THE UNITED STATES
|Disease||Brand name||Company||Cell line|
|Rubella||Takahashi Strain||Kitasato Institute||Rabbit kidney|
|Hepatitis A||Aimmugen||Chemo-therapeutic Institute Japan (Kaketsuken)||Monkey kidney|
We are currently working in conjunction
with the Foreign Manufacturers
to obtain these vaccines in the United States.
Additional Facts - Rubella
The Rubella vaccine, produced by Merck & Company was taken
from an aborted baby during the 1964 rubella epidemic when some mothers were
advised to have abortions, rather than risk their child being born with
Congenital Rubella Syndrome. It was from the 27th
baby aborted and immediately dissected that the active rubella virus was finally
found. It was commonly referred to as RA27/3, where R=Rubella, A=Abortus,
27=27th fetus, 3=third tissue culture explant. The abortionist
collaborated with the Wistar Institute to collect the aborted babies in order to
isolate the virus. The vaccine virus was then
cultivated in the lung tissue of another aborted female baby, approximately 3 months gestation.
(WI-38) This abortion was done for
the mother because "the parents felt they had too many children."
(American Journal Diseases of Children, Vol. 118, 1969).The new
vaccine was developed in Philadelphia, Pa. and tested on orphans. (American
Journal Diseases of Children, Vol. 110, Oct. 1965) Considering that there was
already two licensed rubella vaccines on the market and considering that they
could have done exactly what the Japanese did in order to isolate the rubella
virus (they swabbed the throat of an infected child), it is obvious this vaccine
was created in order to justify fetal tissue research. It is also important to note that
Rubella is basically a harmless childhood disease that is only considered to
have possible serious effects on the unborn child when a pregnant woman is
exposed to the virus during her first trimester. Should this occur, 20-25%
of these cases will develop some form of Congenital Rubella Syndrome, which may
cause malformations of the heart, eyes or brain, deafness, or liver, spleen and
bone marrow problems.
Sources: Christina Abel RN.
Merck & Company
Additional Facts - Hepatitis A
Havrix, the vaccine used to treat Hepatitis-A, uses a virus strain (HM175) propagated in MRC-5 human diploid (lung) cells which were taken from a male fetus aborted at 14 weeks gestation. These cells are lysed to form a suspension which is purified through ultrafiltration and gel permeation chromotography. The method is referenced to a standard using an Enzyme Linked Immunosorbent Assay (E.L.I.S.A.) and is expressed in terms of units (E.L.U.)
Havrix contains a sterile suspension of inactivated virus
strains. The adult dosage consists of not less than 1440 E.L.U. viral
antigen, 0.5mg of aluminum as aluminum hydroxide and 0.5% of 2-phenoxyethanol as
a preservative. Other excipients are amino acid supplement (0.3%) in a
phosphate buffered saline solution, polysorbate 20 (0.05mg/ml), MRC-5 cell
proteins not greater than 5mgg and traces of formalin, not greater than 0.1mg.
Source: SmithKline Beecham www.sb.com (vaccines-Havrix)
Additional Facts - Chickenpox
VARIVAX was developed with the use of aborted fetuses. It uses both the human cell lines, named WI-38 (Wistar Institute) and MRC-5 (Medical Research Council). The vaccine contains residual components of their DNA and protein. The cell lines were derived from the lung tissue of an aborted female at 3 months gestation and an aborted male at 14 weeks gestation. The cells of these fetuses were then developed in a lab culture to produce several vaccines.
VARIVAX also contains MSG (monosodium glutamate) in 2 forms, according to Jack Samuels, an expert on MSG. According to the FDA, MSG is not advised for infants, children, or pregnant women or children of childbearing age, and people with affective (mental/emotional) disorders.
According to VARIVAX product
literature, the vaccine contains gelatin and trace amounts of neomycin, and
should not be given to people allergic to them; it should not be given to anyone
with an immune disorder, or anyone receiving drugs which affect the immune
system such as chemotherapy or steroids; it should not be given to people with
untreated tuberculosis or certain other infections.
Dr. A. Lavin of the Department of Pediatrics, St. Luke’s Medical Center in Cleveland, Ohio, strongly opposed licensing VARIVAX, “Until we actually know...the risks involved in injecting mutated DNA [the vaccine] into the host genome [children].”
Studies show that up to 3% of VARIVAX recipients contract chicken pox from the vaccine, and that some chicken pox cases may be contracted from recently vaccinated children. Vaccine recipients may therefore pose a health risk to pregnant mothers or family members with chronic health problems or compromised immune systems.
Some studies suggest that chicken pox in a vaccinated child may be milder than in an unvaccinated child. However, some experts believe that this may be due to the vaccine suppressing the illness, which could actually signal a more serious underlying chronic condition. For example, “Atypical measles” is a disease that occurs only in people previously vaccinated for measles, and it is far more serious than regular measles. It is not yet known if “atypical chicken pox” cases will appear as a result of the use of VARIVAX.
The FDA VAERS' (Vaccine Adverse Events Reporting System) first year surveillance of VARIVAX included over 1,500 reports. 76 were serious adverse reactions that included 2 deaths. While a VAERS report does not prove a causal relationship between the vaccine and the death or disability that follows, the vaccine is highly suspect in all such reports.
The FDA has stated that fewer than 10% of
serious adverse reactions and deaths following vaccines are reported;
independent researchers cite lower rates. The federal government has paid
families of vaccine killed and disabled children nearly $100 million in taxpayer
dollars each year since 1986 through the National Vaccine Injury Compensation
Source: P.R.O.V.E. (Parents Requesting Open Vaccination Education)
Order Free Brochures
God blessed America when she feared Him, now it appears, she may face His wrath.
For Christian, Patriot and honest secular sites, please click here.
For all of the links to Previous Daily Thoughts prior to today, click here.
want a real bible study?
free web counter
free web counter